Programs & Tools:
Current Procedural Terminology (CPT) Codes Mapped to CVX Codes
Immunization Information Systems Home (IIS) pages:
On This Page:
The following table lists all of the CPT™ codes from the "Immune Globulins and Vaccines, Toxoids" sections of the American Medical Association's Current Procedural Terminology (CPT) 2006, including those that were deleted in CPT 1997 or later. The table also contains CPT Immunization Administration/Vaccine Product codes that were approved for pre-release beginning July 1, 2006 - to date. Click here for more information about the pre-release of CPT vaccine product codes (exit) . CPT codes have been reproduced here with permission from the AMA. CPT five-digit codes, nomenclature and other data are Copyright 2006 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in CPT. The AMA assumes no liability for the data contained herein. Applicable FARS/DFARS restrictions apply to government use. Click here for more information on CPT (exit).
These CPT codes are mapped to the corresponding CVX vaccine code maintained by the Centers for Disease Control and Prevention's National Immunization Program for use in the HL7 data transmission standard by immunization registries. Please note that all of the CVX codes are listed here: including those for which there is a corresponding CPT code, and those for which there is no corresponding CPT code. Click here for the CVX code set.
Questions regarding this table and the CVX code set should be directed to the IIS Technical Assistance Team; CDC, National Centers for Immunization and Respiratory Diseases, Immunization Information Systems Support Branch-Informatics, 1600 Clifton Road, Mailstop E-62, Atlanta, GA 30333.
| Status1 | CPT | CPT Description | CVX | CVX Full Vaccine Name |
|---|---|---|---|---|
| Active | 90281 | Immune globulin (IG), human, for intramuscular use | 86 | immune globulin, intramuscular |
| Active | 90283 | Immune globulin (IGIV), human, for intravenous use | 87 | immune globulin, intravenous |
| Active | 90287 | Botulinum antitoxin, equine, any route | 27 | botulinum antitoxin |
| Active | 90288 | Botulism immune globulin, human, for intravenous use | NA2 | no CVX assigned |
| Active | 90291 | Cytomegalovirus immune globulin (CMV-IGIV), human, for intravenous use | 29 | cytomegalovirus immune globulin, intravenous |
| Active | 90296 | Diphtheria antitoxin, equine, any route | 12 | diphtheria antitoxin |
| Active | 90371 | Hepatitis B immune globulin (HBIG), human, for intramuscular use | 30 | hepatitis B immune globulin |
| Active | 90375 | Rabies immune globulin (RIG), human, for intramuscular and/or subcutaneous use | 34 | rabies immune globulin |
| Active | 90376 | Rabies immune globulin, heat-treated (RIG-HT), human, for intramuscular and/or subcutaneous use | 34 | rabies immune globulin |
| Active | 90378 | Respiratory syncytial virus immune globulin (RSV-IgIM), for intramuscular use, 50 mg, each | 93 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
| Active | 90379 | Respiratory syncytial virus immune globulin (RSV-IGIV), human, for intravenous use | 71 | respiratory syncytial virus immune globulin, intravenous |
| Active | 90384 | Rho(D) immune globulin (RhIG), human, full-dose, for intramuscular use | NA | no CVX assigned |
| Active | 90385 | Rho(D) immune globulin (RhIG), human, mini-dose, for intramuscular use | NA | no CVX assigned |
| Active | 90386 | Rho(D) immune globulin (RhIGIV), human, for intravenous use | NA | no CVX assigned |
| Active | 90389 | Tetanus immune globulin (TIG), human, for intramuscular use | 13 | tetanus immune globulin |
| Active | 90393 | Vaccinia immune globulin, human, for intramuscular use | 79 | vaccinia immune globulin |
| Active | 90396 | Varicella-zoster immune globulin, human, for intramuscular use | 36 | varicella zoster immune globulin |
| No CPT assigned | 117 | varicella zoster immune globulin (Investigational New Drug) Changes made on: June 1, 2006 | ||
| Active | 90399 | Unlisted immune globulin | MC3 | multiple CVX matches - resolve manually |
| Active | 90476 | Adenovirus vaccine, type 4, live, for oral use | 54 | adenovirus vaccine, type 4, live, oral |
| Active | 90477 | Adenovirus vaccine, type 7, live, for oral use | 55 | adenovirus vaccine, type 7, live, oral |
| Active | 90581 | Anthrax vaccine, for subcutaneous use | 24 | anthrax vaccine |
| No CPT assigned | 82 | adenovirus vaccine, NOS | ||
| Active | 90585 | Bacillus Calmette-Guerin vaccine (BCG) for tuberculosis, live, for percutaneous use | 19 | Bacillus Calmette-Guerin vaccine |
| Active | 90586 | Bacillus Calmette-Guerin vaccine (BCG) for bladder cancer, live, for intravesical use | 19 | Bacillus Calmette-Guerin vaccine |
| D-2000 | 90592 | Cholera vaccine, live, for oral use | NF4 | no CVX assigned - not yet FDA-approved |
| No CPT assigned | 56 | dengue fever vaccine | ||
| No CPT assigned | 57 | hantavirus vaccine | ||
| Active | 90632 | Hepatitis A vaccine, adult dosage, for intramuscular use | 52 | hepatitis A vaccine, adult dosage |
| Active | 90633 | Hepatitis A vaccine, pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 83 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
| Active | 90634 | Hepatitis A vaccine, pediatric/adolescent dosage-3 dose schedule, for intramuscular use | 84 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |
| No CPT assigned | 31 | hepatitis A vaccine, pediatric dosage, NOS | ||
| Active | 90636 | Hepatitis A and hepatitis B (HepA-HepB), adult dosage, for intramuscular use | 104 | hepatitis A and hepatitis B vaccine |
| Active | 90645 | Hemophilus influenza b vaccine (Hib), HbOC conjugate (4 dose schedule), for intramuscular use | 47 | Haemophilus influenzae type b vaccine, HbOC conjugate |
| Active | 90646 | Hemophilus influenza b vaccine (Hib), PRP-D conjugate, for booster use only, intramuscular use | 46 | Haemophilus influenzae type b vaccine, PRP-D conjugate |
| Active | 90647 | Hemophilus influenza b vaccine (Hib), PRP-OMP conjugate (3 dose schedule), for intramuscular use | 49 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
| Active | 90648 | Hemophilus influenza b vaccine (Hib), PRP-T conjugate (4 dose schedule), for intramuscular use | 48 | Haemophilus influenzae type b vaccine, PRP-T conjugate |
| No CPT assigned | 60 | herpes simplex virus, type 2 vaccine | ||
| No CPT assigned | 61 | human immunodeficiency virus vaccine | ||
| 90649 | Human Papilloma virus (HPV) vaccine, types 6, 11, 16, 18 (quadrivalent) 3 dose schedule, for intramuscular use | 62 | human papilloma virus vaccine, quadrivalent Changes made on: June 1, 2006 | |
| No CPT assigned | 118 | human papilloma virus vaccine, bivalent | ||
| Active | 90655 | Influenza virus vaccine, split virus, preservative free, for children 6-35 months of age, for intramuscular use | 15 | Influenza virus vaccine, split virus (incl. purified surface antigen) |
| Active | 90656 | Influenza virus vaccine, split virus, preservative free, for use in individuals 3 years of age and above, for intramuscular use | 15 | Influenza virus vaccine, split virus (incl. purified surface antigen) |
| Active | 90657 | Influenza virus vaccine, split virus, for children 6-35 months of age, for intramuscular use | 15 | influenza virus vaccine, split virus (incl. purified surface antigen) |
| Active | 90658 | Influenza virus vaccine, split virus, for use in individuals 3 years of age and above, for intramuscular use | 15 | influenza virus vaccine, split virus (incl. purified surface antigen) |
| D-2002 | 90659 | Influenza virus vaccine, whole virus, for intramuscular or jet injection use | 16 | influenza virus vaccine, whole virus |
| Active | 90660 | Influenza virus vaccine, live, for intranasal use | 111 | influenza virus vaccine, live, attenuated, for intranasal use |
| No CPT assigned | 63 | Junin virus vaccine | ||
| No CPT assigned | 64 | leishmaniasis vaccine | ||
| No CPT assigned | 65 | leprosy vaccine | ||
| Active | 90665 | Lyme disease vaccine, adult dosage, for intramuscular use | 66 | Lyme disease vaccine |
| No CPT assigned | 67 | malaria vaccine | ||
| No CPT assigned | 68 | melanoma vaccine | ||
| Active | 90669 | Pneumococcal conjugate vaccine, polyvalent, for children under five years, for intramuscular use | 100 | pneumococcal conjugate vaccine, polyvalent |
| Active | 90675 | Rabies vaccine, for intramuscular use | 18 | rabies vaccine, for intramuscular injection |
| Active | 90676 | Rabies vaccine, for intradermal use | 40 | rabies vaccine, for intradermal injection |
| No CPT assigned Changes made on: June 1, 2006 |
74 | rotavirus vaccine, tetravalent, live | ||
| No CPT assigned | 122 | rotavirus vaccine, NOS Changes made on: June 1, 2006 |
||
| Active | 90680 | Rotavirus vaccine, pentavalent, 3 dose schedule, live, for oral use | 116 | rotavirus vaccine, pentavalent, live Changes made on: June 1, 2006 |
| Active | 90681 | Rotavirus vaccine, human, attenuated, 2 dose schedule, live, for oral use | 119 | rotavirus vaccine, monovalent, live Changes made on: July 9, 2008 |
| No CPT assigned | 78 | tularemia vaccine | ||
| Active | 90690 | Typhoid vaccine, live, oral | 25 | typhoid vaccine, live, oral |
| Active | 90691 | Typhoid vaccine, Vi capsular polysaccharide (ViCPs), for intramuscular use | 101 | typhoid Vi capsular polysaccharide vaccine |
| Active | 90692 | Typhoid vaccine, heat- and phenol-inactivated (H-P), for subcutaneous or intradermal use | 41 | typhoid vaccine, parenteral, other than acetone-killed, dried |
| Active | 90693 | Typhoid vaccine, acetone-killed, dried (AKD), for subcutaneous use (U.S. military) | 53 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |
| Active (Changes made July 25, 2008) |
90696 (Changes made July 25, 2008) |
Diphtheria, tetanus toxoids, acellular pertussis vaccine and poliovirus vaccine, inactivated (DTaP-IPV), when administered to children 4 years through 6 years of age, for intramuscular use (Changes made July 25, 2008) |
130 (Changes made July 25, 2008) |
Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated (Changes made July 25, 2008) |
| Active Changes made on: Mar. 31, 2005 |
90698 Changes made on: Mar. 31, 2005 |
Diphtheria, tetanus toxoids, and acellular pertussis vaccine, haemophilus influenza Type B, and poliovirus vaccine, inactivated (DTaP - Hib - IPV), for intramuscular use Changes made on: Mar. 31, 2005 |
120 Changes made on: June 1, 2006 |
diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) Changes made on: June 1, 2006 |
| Active | 907005 | Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), for use in individuals younger than seven years, for intramuscular use | 20 | diphtheria, tetanus toxoids and acellular pertussis vaccine |
| No CPT assigned | 106 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens | ||
| No CPT assigned | 107 | diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS | ||
| Active | 90701 | Diphtheria, tetanus toxoids, and whole cell pertussis vaccine (DTP), for intramuscular use | 01 | diphtheria, tetanus toxoids and pertussis vaccine |
| Active | 90702 | Diphtheria and tetanus toxoids (DT) adsorbed for use in individuals younger than seven years, for intramuscular use | 28 | diphtheria and tetanus toxoids, adsorbed for pediatric use |
| Active | 90703 | Tetanus toxoid adsorbed, for intramuscular use | 35 | tetanus toxoid, adsorbed |
| No CPT Assigned | 112 | tetanus toxoid, NOS | ||
| Active | 90704 | Mumps virus vaccine, live, for subcutaneous use | 07 | mumps virus vaccine |
| Active | 90705 | Measles virus vaccine, live, for subcutaneous use | 05 | measles virus vaccine |
| Active | 90706 | Rubella virus vaccine, live, for subcutaneous use | 06 | rubella virus vaccine |
| Active | 90707 | Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use | 03 | measles, mumps and rubella virus vaccine |
| Active | 90708 | Measles and rubella virus vaccine, live, for subcutaneous use | 04 | measles and rubella virus vaccine |
| D-2002 | Rubella and mumps virus vaccine, live, for subcutaneous use | 38 | rubella and mumps virus vaccine | |
| Active | 90710 | Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use | 94 | measles, mumps, rubella, and varicella virus vaccine |
| D-1999 | 90711 | Diphtheria, tetanus toxoids, and pertussis (DTP) and injectable poliomyelitis vaccine | NF | no CVX assigned - not yet FDA-approved |
| Active | 90712 | Poliovirus vaccine, (any type(s)) (OPV), live, for oral use | 02 | poliovirus vaccine, live, oral |
| Active | 90713 | Poliovirus vaccine, inactivated, (IPV), for subcutaneous or intramuscular use Changes made on: Mar. 31, 2005 |
10 | poliovirus vaccine, inactivated |
| No CPT assigned | 89 | poliovirus vaccine, NOS | ||
| Active | 907146 | Tetanus and diphtheria toxoids (Td) adsorbed, preservative free, for use in individuals seven years or older, for intramuscular use | 113 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use |
| D-1999 | 9071466 | Typhoid vaccine | 91 | typhoid vaccine, NOS there is a more current entry |
| Active Changes made on: Mar. 31, 2005 | 90715 Changes made on: Mar. 31, 2005 | Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), for use in individuals 7 years or older, for intramuscular use Changes made on: Mar. 31, 2005 |
115 Changes made on: May |
tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (Tdap) Changes made on: May |
| Active | 90716 | Varicella virus vaccine, live, for subcutaneous use | 21 | varicella virus vaccine |
| Active | 90717 | Yellow fever vaccine, live, for subcutaneous use | 37 | yellow fever vaccine |
| Active | 90718 | Tetanus and diphtheria toxoids (Td) adsorbed for use in individuals seven years or older, for intramuscular use | 09 | tetanus and diphtheria toxoids, adsorbed for adult use |
| Active | 90719 | Diphtheria toxoid, for intramuscular use | NA | no CVX assigned |
| Active | 90720 | Diphtheria, tetanus toxoids, and whole cell pertussis vaccine and Hemophilus influenza B vaccine (DTP-Hib), for intramuscular use | 22 | DTP-Haemophilus influenzae type b conjugate vaccine |
| Active | 90721 | Diphtheria, tetanus toxoids, and acellular pertussis vaccine and Hemophilus influenza B vaccine (DTaP-Hib), for intramuscular use | 50 | DTaP-Haemophilus influenzae type b conjugate vaccine |
| No CPT assigned | 102 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine | ||
| Active | 90723 | Diphtheria, tetanus toxoids, acellular pertussis vaccine, Hepatitis B, and poliovirus vaccine, inactivated (DTaP-HepB-IPV), for intramuscular use | 110 | DTaP- hepatitis B and poliovirus vaccine |
| D-1999 | 90724 | Influenza virus vaccine | 88 | influenza virus vaccine, NOS |
| Active | 90725 | Cholera vaccine for injectable use | 26 | cholera vaccine |
| D-1999 | 90726 | Rabies vaccine | 90 | rabies vaccine, NOS |
| Active | 90727 | Plague vaccine, for intramuscular use | 23 | plague vaccine |
| D-1999 | 90728 | BCG vaccine | 19 | Bacillus Calmette-Guerin vaccine |
| D-1999 | 90730 | Hepatitis A vaccine | 85 | hepatitis A vaccine, NOS |
| D-1997 | 90731 | Hepatitis B vaccine | 45 | hepatitis B vaccine, NOS |
| No CPT assigned | 58 | hepatitis C vaccine | ||
| No CPT assigned | 59 | hepatitis E vaccine | ||
| Active | 90732 | Pneumococcal polysaccharide vaccine, 23-valent, adult or immunosuppressed patient dosage, for use in individuals 2 years or older, for subcutaneous or intramuscular use Changes made on: June 1, 2006 |
33 | pneumococcal polysaccharide vaccine |
| No CPT assigned | 109 | pneumococcal vaccine, NOS | ||
| Active | 90733 | Meningococcal polysaccharide vaccine (any group(s)), for subcutaneous use | 32 | meningococcal polysaccharide vaccine (MPSV4) Changes made on: Mar. 31, 2005 |
| No CPT assigned | 103 | meningococcal C conjugate vaccine | ||
| No CPT assigned | 108 | meningococcal vaccine, NOS | ||
| Active | 90734 | Meningococcal conjugate vaccine, serogroups A, C, Y and W-135 (tetravalent), for intramuscular use | 114 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4) Changes made on: Mar. 31, 2005 |
| Active | 90735 | Japanese encephalitis virus vaccine, for subcutaneous use | 39 | Japanese encephalitis vaccine |
| Active | 90736 | Zoster (shingles) vaccine, live, for subcutaneous injection | 121 | zoster vaccine, live Changes made on: June 1, 2006 |
| D-1999 | 90737 | Hemophilus influenza B | 17 | Haemophilus influenzae type b vaccine, conjugate NOS |
| Active | 90740 | Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (3 dose schedule), for intramuscular use | 44 | hepatitis B vaccine, dialysis patient dosage |
| D-1999 | 90741 | Immunization, passive; immune serum globulin, human (ISG) | 14 | immune globulin, NOS |
| D-1999 | 90742 | Immunization, passive; specific hyperimmune serum globulin (eg, hepatitis B, measles, pertussis, rabies, Rho(D), tetanus, vaccinia, varicella-zoster) | MC | multiple CVX matches - resolve manually |
| Active | 90743 | Hepatitis B vaccine, adolescent (2 dose schedule), for intramuscular use | 43 | hepatitis B vaccine, adult dosage |
| Active | 90744 | Hepatitis B vaccine, pediatric/adolescent dosage (3 dose schedule), for intramuscular use | 08 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
| D-2000 | 90745 | Hepatitis B vaccine, adolescent/high risk infant dosage, for intramuscular use | 42 | hepatitis B vaccine, adolescent/high risk infant dosage |
| Active | 90746 | Hepatitis B vaccine, adult dosage, for intramuscular use | 43 | hepatitis B vaccine, adult dosage |
| Active | 90747 | Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (4 dose schedule), for intramuscular use | 44 | hepatitis B vaccine, dialysis patient dosage |
| Active | 90748 | Hepatitis B and Hemophilus influenza b vaccine (HepB-Hib), for intramuscular use | 51 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
| Active | 90749 | Unlisted vaccine/toxoid | MC | multiple CVX matches - resolve manually |
| No CPT assigned | 11 | pertussis vaccine | ||
| No CPT assigned | 69 | parainfluenza-3 virus vaccine | ||
| No CPT assigned | 70 | Q fever vaccine | ||
| No CPT assigned | 72 | rheumatic fever vaccine | ||
| No CPT assigned | 73 | Rift Valley fever vaccine | ||
| No CPT assigned | 75 | vaccinia (smallpox) vaccine | ||
| No CPT assigned | 105 | vaccinia (smallpox) vaccine, diluted | ||
| No CPT assigned | 76 | Staphylococcus bacteriophage lysate | ||
| No CPT assigned | 77 | tick-borne encephalitis vaccine | ||
| No CPT assigned | 81 | Venezuelan equine encephalitis, inactivated | ||
| No CPT assigned | 80 | Venezuelan equine encephalitis, live, attenuated | ||
| No CPT assigned | 92 | Venezuelan equine encephalitis vaccine, NOS | ||
| No CPT assigned | 95 | tuberculin skin test; old tuberculin, multipuncture device | ||
| No CPT assigned | 96 | tuberculin skin test; purified protein derivative solution, intradermal | ||
| No CPT assigned | 97 | tuberculin skin test; purified protein derivative, multipuncture device | ||
| No CPT assigned | 98 | tuberculin skin test; NOS | ||
| No CPT assigned | 998 | no vaccine administered | ||
| No CPT assigned | 999 | unknown vaccine or immune globulin | ||
| No CPT assigned | 99 | RESERVED - do not use |
Change Log:
July 30, 2008: Updated contact information and related web sites.
July 23, 2008: Added CVX Code 130;
June 1, 2006. Added CVX code 117; added CPT code 90649, and modified CVX code 62; added CVX code 118; modified CPT code 90680, and added CVX code 116; modified CVX code 74; added CVX code 119; added CVX code 120; modified CPT code 90732; added CPT code 90736, and added CVX code 121.
May 10, 2005; Added CVX 115.
March 31, 2005: Added CPT codes 90698, 90714, 90715, and 90734; Added footnote regarding CPT code 90714; Added CVX codes 113 and 114; Revised CPT description for CPT code 90713; Corrected CPT description for CPT code 90733; Added abbreviation to CVX code 32;
Notes:
1Status - "Active": the code is currently listed in CPT 2002 or later; "D-19xx or D-2000": the code was deleted from CPT in the CPT version year indicated.
2NA - There is no CVX equivalent for this CPT code.
3MC - When this "unlisted" CPT code is used, text should be included to identify the vaccine or immune globulin administered. The complete CVX code set should be examined to determine if there is an equivalent CVX code. If none is found, there is no CVX equivalent for this CPT code.
4NF - There is no CVX equivalent for this CPT code. However, when the vaccine is licensed by the FDA and available for use, a CVX code will be assigned.
5(CPT errata) - Code 90700 was revised for CPT 2004 to include the italicized text. This text was omitted from the print version of CPT.
6Note that there are two (2) entries for CPT code 90714.
Originally shown as the code for typhoid vaccine dating from 1982, it was deleted in 1999 when four new CPT codes were added for specific typhoid vaccines, that is, 90690, 90691, 90692, and 90693. This entry for 90714 is shown 'grayed-out' to indicate there is a more current entry.
In the 'early release' of CPT codes by AMA/CPT for 2006, 90714 has been re-issued as shown for Td preservative free vaccine. This information is available on the AMA/CPT web site at: www.ama-assn.org/ama/pub/category/10902.html (exit)
For further information on HL7 immunization data exchange and the CVX code set, contact the IIS Technical Assistance Team at:
Immunization Information System Support Branch - Informatics
1600 Clifton Road
Mailstop: E-62
Atlanta, GA 30333
Disclaimer: Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. The CDC is not responsible for the content of the individual organization webpages found at these links.
Content last reviewed on June 1, 2006
Content Source: National Center for Immunization and Respiratory Diseases
